Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine

News   May 14, 2013

 
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine
 
 
 

RELATED ARTICLES

Evolution Threatens Efficient Bioproduction Scale-Up

News

The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.

READ MORE

Blood Cancers are Outsmarting the Immune System, But How?

News

Researchers have discovered how some of the blood cancers known as myeloproliferative neoplasms (MPNs) evade the immune system.

READ MORE

Can You Eat Cells? Computer Model Predicts Organisms that Use Phagocytosis

News

A computer model developed by Museum researchers may provide new insight into the origins of phagocytosis, the process by which single-celled organisms “eat” other cells as a means of absorbing nutrients or eliminating pathogens.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE